OverviewChartNewsTraderScreen

DZ Bank Call 125 AMD 20.06.2025/  DE000DJ87RT1  /

Frankfurt Zert./DZB
22/05/2024  12:35:20 Chg.+0.010 Bid22/05/2024 Ask22/05/2024 Underlying Strike price Expiration date Option type
0.920EUR +1.10% 0.920
Bid Size: 7,500		 0.940
Ask Size: 7,500		 Advanced Micro Devic... 125.00 USD 20/06/2025 Call
GlobeNewswire 21/05 AMD Instinct MI300X Accelerators Power Microsoft Azure OpenAI Service Workloads and New Azure ND MI3...
GlobeNewswire 21/05 AMD Expands EPYC CPU Portfolio to Bring New Levels of Performance and Value for Small and Medium Bus...
GlobeNewswire 21/05 Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroi...
GlobeNewswire 21/05 YieldMax™ Launches Option Income Strategy ETF on the VanEck® Gold Miners ETF (GDX®)
TeleTrader 20/05 Microsoft will 'soon welcome' AMD, Intel chips
GlobeNewswire 20/05 Broadcom Revolutionizes AI Networking Landscape with High-Performance 400G RoCE/RDMA Ethernet NICs
Newsfile Corp 16/05 FDA Grants AI-Powered Notal Vision Home OCT "SCANLY" De Novo Marketing Authorization
GlobeNewswire 15/05 Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Cor...
GlobeNewswire 14/05 AMD Announces Upcoming Events for the Financial Community
GlobeNewswire 14/05 Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facilit...
GlobeNewswire 14/05 Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 13/05 Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5...
GlobeNewswire 13/05 AMD Remains the Partner of Choice for World’s Fastest and Most Efficient High Performance Computing ...
GlobeNewswire 09/05 Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 09/05 Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlight...
GlobeNewswire 09/05 4DMT Reports First Quarter 2024 Financial Results and Operational Highlights
GlobeNewswire 08/05 Alkeus Pharmaceuticals Announces Positive Interim Results Demonstrating No Signs of Disease Progress...
GlobeNewswire 08/05 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire 08/05 AMD Receives IEEE 2024 Corporate Innovation Award for Leadership in Chiplet Design for High-Performa...
GlobeNewswire 08/05 Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
GlobeNewswire 08/05 EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporat...
GlobeNewswire 07/05 Ocular Therapeutix™ Reports First Quarter 2024 Results
GlobeNewswire 07/05 Optiver Chooses AMD Enterprise Portfolio to Power its Data Center Modernization, Enabling New Era of...
GlobeNewswire 07/05 Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results
GlobeNewswire 07/05 Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)